Endotoxin Testing Market Report 2024 (Global Edition)

Global Endotoxin Testing Market Report 2024 Market Size Split by Type (Endotoxin Detection Products, LAL Test Reagents, Mycoplasma Detection & Removal, PCR Mycoplasma Detection Kit, Mycoplasma Elimina...

Endotoxin Testing Market Report Description

We have various report editions of Endotoxin Testing Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Competitive Landscape of the Endotoxin Testing Market

Key players deploy strategic initiatives such as product innovations, partnerships, and mergers. Companies prioritize R&D to introduce cutting-edge reagents, ensuring a competitive edge. Robust distribution networks and adherence to quality standards amplify market presence, fostering an environment where agility and innovation define industry leaders.

Endotoxin Testing Industry News

• April 2021: Lonza has declared an expansion to its popular PyroTec® PRO Automated Robotic Solution for endotoxin testing. The recent PyroWave® Reader add-on has been designed specifically for utilization with the sustainable PyroGene® Recombinant Factor C (rFC) Assay.

(Source: https://www.lonza.com/news/2021-04-12-13-00 )

Top Companies Market Share in Endotoxin Testing Industry: (In no particular order of Rank)

• Charles River
• Pacific BioLabs
• Merck KGaA
• Lonza
• Nelson Laboratories LLC 
• Bio-Synthesis Inc
• Biogenuix Medsystems Pvt. Ltd
• GenScript
• Thermo Fisher Scientific Inc
• SGS SA
• WuXi AppTec
• Sartorius AG
• Pace Analytical Services LLC
• TOXIKON
• Eurofins Scientific
• Source BioScience
• STERIS
• Accugen Labs
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

In terms of revenue, the North American Endotoxin Testing Market share was 40% of the total market

According to Cognitive Market Research, North America dominated the market in 2024 and accounted for around 40% of the global revenue due to stringent regulatory measures imposed by agencies like the FDA, ensuring safety in pharmaceuticals and medical devices. The region's robust pharmaceutical and biotechnology industries, coupled with technological advancements in testing methods, fuel demand. Rising concerns about infectious diseases and a focus on quality control further bolster market growth, making North America a key player in the global endotoxin testing market.

Europe is the fastest-growing region over the projected period, owing to robust testing in pharmaceuticals and medical devices. The region's burgeoning pharmaceutical and biotechnology sectors, coupled with advancements in drug development, fuel the need for reliable testing methods. Additionally, a focus on quality control and rising awareness of patient safety further propel market growth in Europe.

The current report Scope analyzes Endotoxin Testing Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only. To learn more about geographical trends request the free sample pages. Contact US!

Asia Pacific Endotoxin Testing Market

According to Cognitive Market Research, the global endotoxin testing market size was estimated at USD 195.6 Million, out of which Asia Pacific held the market of around 23% of the global revenue with market size of USD 44.99 million in 2024 and will grow at a compound annual growth rate (CAGR) of 12.8% from 2024 to 2031 due to region's rising awareness of infectious disease control. As the region experiences rapid economic growth and technological advancements, demand for reliable endotoxin testing solutions is poised to grow, ensuring product safety and regulatory compliance in the healthcare sector. According to Cognitive Market Research, the demand for endotoxin removal products is rising, spurred by the need for effective contamination control in medical devices, pharmaceuticals, and bioprocessing industries, contributing to market growth. In conclusion, the region's endotoxin testing market is driven by continuous research and development in reagent sensitivity, cost-cutting, and less turnaround time.

• According to Cognitive Market Research, the size of the Chinese endotoxin testing market size was valued at USD 20.24 million in 2024 and is projected to grow at a CAGR of 12.3% during the forecast period. This is due to increasing health standards and demand for disease-specific drugs.
• The Japan endotoxin testing market is projected to grow at a CAGR of 11.3% during the forecast period, with a market size of USD 6.21 million in 2024. This is due to the country's expanding biopharmaceutical industry.
• The India endotoxin testing market had a market share of USD 5.40 million in 2024 and is projected to grow at a CAGR of 14.6% during the forecast period. 
• The South Korean endotoxin testing market is projected to grow at a CAGR of 11.9% during the forecast period, with a market size of USD 4.50 million in 2024.
• The Australian endotoxin testing market is projected to grow at a CAGR of 12.5% during the forecast period, with a market size of USD 2.34 million in 2024.
• The South East Asia endotoxin testing market is projected to grow at a CAGR of 13.8% during the forecast period, with a market size of USD 3.10 million in 2024.
• The Rest of Asia Pacific endotoxin testing market is projected to grow at a CAGR of 12.6% during the forecast period, with a market size of USD 3.19 million in 2024.

South America Endotoxin Testing Market

According to Cognitive Market Research, the global endotoxin testing market size was estimated at USD 195.6 Million, out of which the Latin America market has more than 5% of the global revenue with market size of USD 9.78 million in 2024 and will grow at a compound annual growth rate (CAGR) of 10.2% from 2024 to 2031 owing growing healthcare infrastructure and emphasis on product safety contribute to the demand for reliable testing solutions, fostering market growth in this dynamic and evolving market landscape. According to Cognitive Market Research, the region's expanding pharmaceutical and biotechnology sectors, stringent regulatory standards, and increasing focus on quality control drive the market. Gel clot endotoxin testing, a widely used method, ensures product safety and compliance, contributing to regional market growth. In conclusion, the region's endotoxin testing market is driven by the growing requirement for endotoxin-free clearance of devices.

• According to Cognitive Market Research, Brazil's endotoxin testing market size was valued at USD 4.19 million in 2024 and is projected to grow at a CAGR of 10.8% during the forecast period. Endotoxin testing flourished in Brazil due to the nation's growth of R&D outsourcing activities.
• The Argentina endotoxin testing market had a market share of USD 1.64 million in 2024 and is projected to grow at a CAGR of 11.1% during the forecast period. The presence of many home-grown life sciences and healthcare companies.
• The Colombia endotoxin testing market is projected to grow at a CAGR of 10.0% during the forecast period, with a market size of USD 0.87 million in 2024.
• The Peru endotoxin testing market is projected to grow at a CAGR of 10.4% during the forecast period, with a market size of USD 0.80 million in 2024.
• The Chile endotoxin testing market is projected to grow at a CAGR of 10.5% during the forecast period, with a market size of USD 0.70 million in 2024.
• The Rest of the Latin America endotoxin testing market is projected to grow at a CAGR of 9.3% during the forecast period, with a market size of USD 1.57 million in 2024.

Europe Endotoxin Testing Market

According to Cognitive Market Research, the global endotoxin testing market size was estimated at USD 195.6 Million, out of which Europe held the major market of more than 30% of the global revenue with market size of USD 58.68 million in 2024 and will grow at a compound annual growth rate (CAGR) of 9.3% from 2024 to 2031 due to growing pharmaceutical and biotechnology industries, coupled with a focus on quality control, propel the demand for reliable testing solutions to ensure product safety and compliance. According to Cognitive Market Research, the region's robust pharmaceutical industry drives demand for reliable testing methods to ensure product safety and compliance. Additionally, advancements in testing technologies and a growing emphasis on quality control further propel market growth. In conclusion, an increase in the demand for endotoxin tests in chronic and infectious disease management drives the region's endotoxin testing market.

• The United Kingdom's endotoxin testing market had a market share of USD 9.86 million in 2024 and is projected to grow at a CAGR of 10.1% during the forecast period. This is due to the country's adoption of rapid endotoxin testing methods.
• The French endotoxin testing market is projected to grow at a CAGR of 8.5% during the forecast period, with a market size of USD 5.40 million in 2024.
• According to Cognitive Market Research, the size of the German endotoxin testing market was valued at USD 11.62 million in 2024 and is projected to grow at a CAGR of 9.5% during the forecast period. In Germany, the endotoxin testing market surged due to the presence of major market players. 
• The Italian endotoxin testing market is projected to grow at a CAGR of 8.7% during the forecast period, with a market size of USD 5.05 million in 2024.
• The Russian endotoxin testing market is projected to grow at a CAGR of 8.3% during the forecast period, with a market size of USD 9.10 million in 2024.
• The Spanish endotoxin testing market is projected to grow at a CAGR of 8.4% during the forecast period, with a market size of USD 4.81 million in 2024.
• The Luxembourg endotoxin testing market is projected to grow at a CAGR of 9.4% during the forecast period, with a market size of USD 1.82 million in 2024.
• The Portugal endotoxin testing market is projected to grow at a CAGR of 9.1% during the forecast period, with a market size of USD 1.23 million in 2024.
• The Greece endotoxin testing market is projected to grow at a CAGR of 9.6% during the forecast period, with a market size of USD 0.70 million in 2024.
• The Rest of Europe's endotoxin testing market is projected to grow at a CAGR of 8.0% during the forecast period, with a market size of USD 9.10 million in 2024.

Middle East and Africa Endotoxin Testing Market

According to Cognitive Market Research, the global endotoxin testing market size was estimated at USD 195.6 Million, out of which the Middle East and Africa held the major market of around 2% of the global revenue with market size of USD 3.91 million in 2024 and will grow at a compound annual growth rate (CAGR) of 10.5% from 2024 to 2031 due to the presence of robust life sciences infrastructure, and high requirement for endotoxin testing. The presence of many pharmaceutical, medical device, and biotechnology companies and their requirements for advanced kits and systems for testing drive the market growth. According to Cognitive Market Research, the market is driven by adopting microbial air testing (MAT) for endotoxin detection, which enhances quality control measures and ensures compliance and product safety in the region's healthcare and pharmaceutical sectors. In conclusion, rising FDA approvals for endotoxin testing tools drive the region's endotoxin testing market.

• According to Cognitive Market Research, the GCC Countries' endotoxin testing market size was valued at USD 1.67 million in 2024 and is projected to grow at a CAGR of 11.3% during the forecast period. Endotoxin testing flourished in the GCC Countries due to the increase in the number of medical device manufacturing companies.
• The Egyptian endotoxin testing market is projected to grow at a CAGR of 10.8% during the forecast period, with a market size of USD 0.41 million in 2024.
• The South African endotoxin testing market is projected to grow at a CAGR of 11.5% during the forecast period, with a market size of USD 0.62 million in 2024. Endotoxin Testing flourished in South Africa due to the region's investments in innovative technology to improve the performance of endotoxin testing.
• The Turkish endotoxin testing market is projected to grow at a CAGR of 10.0% during the forecast period, with a market size of USD 0.34 million in 2024.
• The Nigeria endotoxin testing market is projected to grow at a CAGR of 9.6% during the forecast period, with a market size of USD 0.41 million in 2024.
• The Rest of MEA endotoxin testing market is projected to grow at a CAGR of 9.5% during the forecast period with a market size of USD 0.46 million in 2024.

North America Endotoxin Testing Market

According to Cognitive Market Research, the global endotoxin testing market size was estimated at USD 195.6 Million, out of which North America held the major market of more than 40% of the global revenue with a market size of USD 78.24 million in 2024 and will grow at a compound annual growth rate (CAGR) of 9.0% from 2024 to 2031 due to stringent regulatory standards enforced by bodies like the FDA, rising demand for pharmaceutical and biotech products, and technological advancements enhancing testing efficiency, ensuring product safety, and compliance in various industries. According to Cognitive Market Research, PCR mycoplasma detection kits drive market growth with their rapid, sensitive, and specific detection capabilities, ensuring product safety and regulatory compliance in the region. In conclusion, the endotoxin testing market in North America is driven by technological advancements, strict regulatory guidelines for medical devices, and regulatory delays.

• According to Cognitive Market Research, the US had a major share in the endotoxin testing market, with a market size of USD 61.73 million in 2024, and is projected to grow at a CAGR of 8.8% during the forecast period. The nation’s growing adoption of technological assessment for biologics and biopharmaceuticals.
• The Canadian endotoxin testing market had a market share of USD 9.39 million in 2024 and is projected to grow at a CAGR of 9.8% during the forecast period. The nation's increased public and regulatory concerns about product safety.
• The Mexico endotoxin testing market is projected to grow at a CAGR of 9.5% during the forecast period, with a market size of USD 7.12 million in 2024.

Endotoxin Testing Market Analysis

Endotoxin Testing Type Segment Analysis

According to Cognitive Market Research, the LAL test reagents held the major market stake over the projected period as they utilized reagents derived from horseshoe crab blood, which remains a cornerstone in endotoxin detection. Its widespread adoption is fueled by its sensitivity, specificity, and compatibility with various sample types, ensuring product safety and regulatory compliance in industries prioritizing quality control.

PCR mycoplasma detection kit is the fastest-growing category over the forecast period as it offers rapid and sensitive detection of mycoplasma contamination in cell cultures, bolstering quality control in biopharmaceutical manufacturing. This kit delivers a convenient and reliable solution for ensuring product security and regulatory subordination in cell-based research and production processes.

• Endotoxin Detection Products
• LAL Test Reagents
• Mycoplasma Detection & Removal
• PCR Mycoplasma Detection Kit
• Mycoplasma Elimination Cocktail
• Mycoplasma Detection and Elimination Custom Services
• Accessories
• Instrumentation
  • Endotoxin Removal Products
  • Low Endotoxin Recovery Products
• Lipopolysaccharides

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Endotoxin Testing Industry. Request a Free Sample PDF!

Endotoxin Testing Application Segment Analysis

According to Cognitive Market Research, pharmaceutical manufacturing holds a prominent market share due to the increasing focus on quality control. Consequently, the market experiences sustained expansion as pharmaceutical manufacturers prioritize compliance with regulatory standards to guarantee product safety and regulatory approval.

Medical device manufacturing is the fastest-growing category over the forecast period as it ensures compliance with regulatory bodies like the FDA, driving demand for testing solutions. Additionally, the rising complexity and diversity of medical devices necessitate robust quality control measures, further fueling market growth. As a result, endotoxin testing plays a vital role in maintaining the security and efficacy of medical devices.

• Medical Device Manufacturing
• Pharmaceutical Manufacturing
• Packaging Manufacture
• Raw Materials Production

The above Graph is for representation purposes only. This chart does not depict actual Market share. Please purchase the Endotoxin Testing market report 2024 Edition by contacting our team.

Endotoxin Testing Testing Methods Segment Analysis

According to Cognitive Market Research, chromogenic endotoxin testing holds a prominent market share as it is a rapid and reliable alternative that utilizes colorimetric reactions for detection. Its advantages include high specificity, sensitivity, and ease of use, positioning it as a driver in the market's growth, especially in industries emphasizing rapid and accurate endotoxin detection.

Turbidimetric endotoxin testing is the fastest-growing category over the forecast period due to rising infectious disease incidences, technological advancements, and a growing focus on quality control. It measures the turbidity change caused by endotoxins, offering rapid, sensitive, and quantitative results, thus contributing significantly to market growth and ensuring product safety in various industries.

• Gel Clot Endotoxin Testing
• Chromogenic Endotoxin Testing
• Turbidimetric Endotoxin Testing

Endotoxin Testing Test Type Segment Analysis

According to Cognitive Market Research, LAL endotoxin testing holds a prominent market share as it is a cornerstone method and benefits from its specificity and sensitivity, ensuring product safety and regulatory compliance. With an increasing focus on quality control and technological advancements, LAL Endotoxin Testing remains indispensable in various sectors, including pharmaceuticals, medical devices, and healthcare.

MAT endotoxin testing is the fastest-growing category over the forecast period, offering rapid and reliable results. Its high sensitivity and specificity make it increasingly preferred, aiding pharmaceutical quality control and ensuring product safety, particularly in parenteral drugs, medical devices, and biologics.

• LAL Endotoxin Testing
• MAT Endotoxin Testing
• Rabbit Pyrogen Endotoxin Testing
• Recombinant Factor C Endotoxin Testing

Author's Detail

Anushka Gore

Research Associate at Cognitive Market Research

LinkedIn

Profile

Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.

Author's Conclusion